United States of America
Tom has served as President and C.E.O of Aries Pharmaceuticals, Inc. since it’s inception in July 2016. Tom has over three decades of strategic and operational leadership experience building effective commercial organizations and launching new products. From January 2004 to January 2014 Tom served as Vice President, Marketing and National Accounts at Santarus Pharmaceuticals, Inc., a specialty biopharmaceutical company acquired by Salix Pharmaceuticals in 2014 for $2.6 billion. In this role Tom helped create the Company’s commercial organization and led the Marketing and National Accounts efforts. From March 2002 to December 2003 Tom served as Senior Director of Marketing at Neurocrine Biosciences, Inc. where he helped establish Neurocrine’s commercial strategy. From May 1996 to February 2002 Tom held various commercial leadership positions with Agouron Pharmaceuticals. In 1999, Warner Lambert acquired Agouron for $2.2 billion, and Pfizer subsequently acquired Warner Lambert in 2000.